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Ethnopharmmacological relevance: Aleurites moluccana is a medicinal plant popularly used to treat pain,
fever, asthma, hepatitis, gastric ulcer and inﬂammatory process in general. Recently, pre-clinical studies
have demonstrated that the dry extract obtained from A. moluccana leaves was effective as analgesic,
anti-inﬂammatory and wound healing.
Aim: The present study has aimed to evaluate the mechanisms involved in the topical anti-inﬂammatory
effects of the semisolid containing 10 mg/g of A. moluccana dried extract.
Material and Methods: Ear edema induced by croton oil (2.5%) in mice was used throughout the study.
The level of cytokines tumour necrosis factor (TNF) and interleukine-1β (IL-1β) and chemokine kerati-
nocyte chemoattractant (CXCL1/KC), and neutrophil migration were quantiﬁed. The histological analysis
has also been performed.
Results: The topical treatment with the semisolid was able to signiﬁcantly inhibite the ear edema
(35.7777.35%). This effect was accompanied by the reduction of leukocyte migration, as well as TNF
(53.75712.96%), IL-1β (38.3675.92%), and CXCL1/KC (62.29711.65%) decreased levels.
Conclusions: This study demonstrated for the ﬁrst time the mechanisms involved in the topical anti-
inﬂammatory effect presented by the semisolid containing A. moluccana dried extract pointing as the
main mechanism is the reduction in the leukocyte migration and consequently resulting in diminished
levels of cytokins and chemokines, indicating this herbal product as a promissor anti-inﬂammatory
phytomedicine to treat skin inﬂammatory diseases.
& 2015 Elsevier Ireland Ltd. All rights reserved.1. Introduction
The skin inﬂammation is widely studied due to its complexity
and relevance to human health, considering the high number of
people that suffer from chronic inﬂammation (Alam et al., 2011).
Skin damage is generally associated with inﬂammation due to skin
burns or inﬂammatory illness such as psoriasis, contactor atopic
dermatitis, vulgaris acne, skin wounds, among others (Gittler et al.
2013; Haertel et al., 2014; Kendall and Nicolaou, 2013; Wagener
et al., 2013).
The skin is physiologically considered as an active barrier,rved.
em CiênciasFarmacêuticas,
Itajaí (UNIVALI), Rua Uruguai,
) 3341 7796.
Garcia Couto).consisting of cellsthat regulate the chemical mediators secretion,
such as cytokines and bioactive lipids. These mediators are re-
sponsible forinitiatingtheimmune response and forcontroling the
inﬂammatory cascade, leading to an efﬁcient inﬂammatory re-
solution. However, in some cases the inﬂammatory process can
become uncontrolled, hindering the process resolution, culmi-
nating in a pathological condition (Kendall and Nicolaou, 2013). In
this context, the search for new therapies that control the skin
inﬂammatory process, including the release of cytokines and
others inﬂammatory mediatorsmight become an important ther-
apeutic strategy for chronic disease (Hilling, 2010).
The medicial plants have a great relevance in the treatment or
relief of inﬂammation, mainly in countries in developmentwhere
the folk medicine is largely used to treat many diseases. In Brazil,
the use of phytomedicine has received the encouragement of the
National Policy on Integrative and Complementary Practices of the
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Policy on Medicinal Plants and Herbal Medicines (PNPMF) (Car-
valho et al., 2011).
Aleurites moluccana (L.) Willd, belonging to the Euphorbiaceae
family and popularly known in Brazilas “nogueira de iguape” and
“noz da India”, is a tree native from Indonesia that has became
acclimatized and well-adaptated to the south and southwest of
Brazil. In folk medicine, A. moluccana leaves have been used to
treat fever, asthma, hepatitis, headache, gastric ulcer and in-
ﬂammatory process in general (Villalobos and Castellanos, 1992;
Foster, 1996; Quintão et al., 2014). Recently, Cesca et al. (2012)
demonstrated the topical anti-inﬂammatory effect of A. moluccana
leaves dried extract. The semisolid presented reduction of ear
edema induced by croton oil and also improved the wound heal-
ing.This study had the aim of improve the knowledge about the
mechanisms throughout the A. moluccana dried extract presented
signiﬁcant topical anti-inﬂamatory effects providing more scien-
tiﬁc evidences to support its use in the folk medicine.2. Material and methods
2.1. Reagents and samples
The ELISA kits for mouse IL-1β, TNF, and CXCL1/KC were pur-
chased from R&D Systems (Minneapolis, MN). The hydrogen per-
oxide (H2O2), Tween 20, EDTA, aprotinin, and PBS tablets were
purchased from Sigma Chemical Co. (St. Louis, MO). The drugs
were prepared in saline solution (0.9% NaCl). Ethanol P.A. (Solven),
Ethanol Absolute (Meta Química), DMSO (Emplura), Yellowish
eosin-C/45380 (ﬁne chemicals Vetec), Entelan (Merck), Ethyl Ether
(Diethyl) (Vetec Chemistry), Croton oil (Sigma), Triton X-100
(Sigma), Xylene (Solven).
2.2. Plant extract and semisolid preparation
The standardized hydroalcoholic spray dried extract of A. mo-
luccana leaves, with 20% of dioxide colloidal silicon, was produced
by Eurofarma industry, and donated by the Pharmaceutical Tech-
nology Laboratory of UNIVALI. The semisolid, used as vehicle, was
prepared by mixing Sepigel 305, vaseline, crodalan, isopropyl
myristate, BHT, cetostearyl alcohol, Phenonips, EDTA and water
with slight warming. The extract was added at 1% with the aid of
propylene glycol. The formulations were packed in aluminium
tubes, with a seal and polypropylene cover.
Semisolid containing dexamethasone acetate 1 mg/g, manu-
factured by EMS laboratory S/A (batch 603 479), was commercially
purchased and used as positive control drug.
2.3. Pharmacological assays
2.3.1. Animals and ethics statement
Male Swiss mice (25–30 g) were provided by Central Animal
House of the Universidade do Vale do Itajaí (UNIVALI, Itajaí, Brazil).
The animals were housed in standard cages, at room temperature
(25 °C72 °C) with 12 h dark/12 h light cycles, and supplemented
with food and water ad libitum.
The project was approved by the Institutional Animal Care and
Use Committee at the Universidade do Vale do Itajaí (Protocol
number: 019/2014). All procedures were performed according to
the Brazilian Socienty of Science of Laboratory Animals guidelines
for the proper care and use of experimental animals.
2.3.2. Croton oil-induced ear edema
To evaluate the topical anti-inﬂammatory effect, the semisolid
containing standardized spray dried extract of A. moluccana(10 mg/g), dexamethasone (1 mg/g) or vehicle was topically ap-
plied (50 mL) to the inner surface of the mouse right ear. The croton
oil (2.5% diluted in acetone; 20 mL/ear) was applied to the outside
surface of the right ear 30 min after the treatment with the
semisolid. The ears thickness was measured before and 6 h after
inﬂammation induction, using a micrometer (Mitutoyo Series
293). The micrometer was applied near the tip of the ear, slightly
distal to the cartilaginous ridges, and the thickness was recorded
in mm (Calixto et al., 1991).
2.3.3. Determination of cytokine levels
The IL-1β, TNF and CXCL1/KC levels were determined in the ear
tissue collected 6 h after croton oil application. The samples (6 mm
punch) were homogenized in PBS containing 0.05% Tween 20,
0.1 mM phenylmethylsulphonyl ﬂuoride (PMCF), 0.1 mM benza-
methonium chloride, 10 mM ethylenediaminetetraacetic acid
(EDTA) and 20 UI aprotinin A.The homogeinate was centrifuged at
3000 g for 10 min before being stored at -70 °C until further ana-
lysis. IL-1β, TNF, and CXCL1/KC levels were quantiﬁed using en-
zyme-linked immunosorbent assay (EIA) kits accoding to the
manufacturer’s speciﬁcations (R&D Systems). The resuls were ex-
pressed as pg/mL of IL-1β, TNF or CXCL1/KC.
2.3.4. Myeloperoxidase (MPO) assay
The MPO, a hemoprotein located in the azurophilic granules of
neutrophils, was used as a biochemical marker for neutrophil in-
ﬁltration in the studied tissues. MPO activity was mensured ac-
cording to the method originally described by Bradley et al. (1982).
Animals were treated with 50 mL of semisolids. One group received
the semisolid containging A. molucana extract (1%), other received
vehicle, and another dexamethasone commercial semisolid (1 mg/
g) 30 min before the croton oil (2.5%) application. The ear tissue
samples (6 mm punch) were collected 6 h after the croton oil
application and then homogenized at 5% (w/v) in EDTA/NaCl
buffer (pH 4.7) and centrifuged at 10,000 rpm for 15 min at 4 °C.
The pellet was re-suspended in 0.5% hexadecyltrimethyl ammo-
nium bromide buffer (HTAB) and the samples were frozen and
thawed three times in liquid nitrogen. The samples were cen-
trifuged (10.000 rpm, 15 min, 4 °C) and 25 mL of the supernatant
was used for the MPO assay. The enzymatic reaction was assessed
with 1.6 mM tetramethylbenzidine (TMB), 80 mM sodium phos-
phate buffer pH 7.2, and 0.3 mM hydrogen peroxide. The absor-
bance was measured at 650 nm. The results are expressed as the
optical density (OD) per milligram of tissue.
2.3.5. Histological analysis
Ear tissue samples (6 mm punch) were collected 6 h after cro-
ton oil treatment and ﬁxed in 4% paraformaldehyde solution in
PBS for 24 h and preserved in 70% EtOH until the beginning of the
dehydration process (Rulih et al., 2011). Each sample was em-
bedded in parafﬁn, sectioned in 3 mm slices andstained with hae-
matoxylin–eosin (HE). The integrity of the epidermis, leukocyte
inﬁltration, dermis thickness and edema were assessed in re-
presentative areas using 100x and 400x of increase.
2.4. Statistical analysis
Data were expressed as means7S.E.M. Differences between
means were determined by analysis of variance (ANOVA) followed
by Dunnett's post hoc using the software GraphPad Prism 5. The
data was considered signiﬁcant when po0.05.
3. Results and discussion
The analiysis of the mechanism involved in the topical anti-
inﬂammatory effect obtained with the semisolid containing A.
Fig. 1. Inﬂuence of pretreatment with topical cream containing dry extract of A.
moluccana 1% on the ear edema induced by topical administration of croton oil.
Mice received topic pre-treatment (50 mL/right ear, inner surface) for treated
groups except the control, 30 min before application of croton oil (20 mL/right ear, l
outer surface). Values represent the mean7SEM of the difference between the
measurements of time zero and after installation of the inﬂammatory response in
animal groups (n¼6). Statistical analysis was performed using ANOVA followed by
Newman-Keuls test. Asterisks denote **po0.01, *** p o0.001) for treatments that
differ from the control group.
Fig. 3. Effect of topical cream containing dry extract of A. moluccana 1% on the
activity of myeloperoxidase after 6 h of application of croton oil. Mice received
topic pre-treatment (50 mL/right ear, inner surface) for the treated groups, except
for control 30 min before the application of the cróton oil (20 mL/ right ear, outer
surface). Values represent the mean of 4-5 animals and the vertical lines indicate
SEM Statistical analysis was performed with ANOVA followed by Newman-Keuls
test. Asterisks denote p o0.001 for treatments that differ from the control group.
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model induced by croton oil (2.5%) in mice (Fig. 1). The topical
croton oil (2.5%) application on the ear skin resulted in the in-
crease of the ear thickness, as presented in Fig. 1. The animals pre-
treated with the semisolid containing the plant extract or dex-
amethasone, the drug used as positive control, was able to sig-
niﬁcantly reduce the edema with inhibition values of
35.7777.35% and 97.6972.30%, respectively. Cesca et al. (2012)
have demonstrated that a semisolid of A. moluccana (1%) sig-
niﬁcantly prevented the ear thickness increase (64.8076.20%)
when compared with the vehicle. It is important to mention that
the semisolid composition previously used by the author was
different, what could justify the difference between the achived
inhibitions.
It is important to analyse the pharmacological events iniciated
by the croton oil administration, since the mechanism involved in
the topical anti-inﬂammatory effect of A. moluccana dried extract
is the main goal of this study. The ear-edema induced by croton oil
is largely used in pre-clinical studies (Carlson et al., 1985). The
croton oil is an irritant agent that promotes tissue acute reaction
by the release of several inﬂammatory mediators (Cabrini et al.,
2011; Baumgartner et al., 2011; Domiciano et al., 2013; Chen et al.,
2012; Fabri et al., 2013; Borges et al., 2013; Chibli et al., 2014). The
croton oil-induced response after topical application is character-
ized by edema caused by vasodilation and leukocyte inﬁltration.
These events are evoked by protein kinase C (PKC) phosphoryla-
tion and subsequent phospholipase A2 (PLA2) activation. In theFig. 2. -Effect of topical pre-treatment cream containing dry extract of A. moluccana 1% o
induced by topical administration of croton oil. Mice received topic pre-treatment (50
application of croton (20 mL/right ear oil outer surface). Values represent the mean of 4-
induction of edema induced by croton oil due to the dosage of processing of KC Chemokin
by Newman-Keuls test. Asterisks denote ** p o0.01, *** p o0.001) for treatments thatsequence, the arachidonic acid (AA) cascade is initiated and leu-
kotrienes, prostaglandins and cytokine are produced, leading to
the inﬂammatory processinstallation (Carlson et al., 1985; Cabrini
et al., 2011; Domiciano et al., 2013; Chibli et al., 2014).
In fact, the main goal of this study was to investigate the me-
chanisms troughtout the extract causes edema inhibition. In this
series of experiments we ﬁrstly investigated the effect of pre-
treatment with the semisolid containing A. moluccana extract in
the production of inﬂammatory mediators induced by croton oil in
mice's ears. The obtained data has shown that both extract and
dexamethasone, applied 30 min before the croton oil, signicantly
reduced the CXCL1/KC, IL-1β and TNF levels, with inhibition values
of 62.29711.65%, 38.3675.92% and 53.75712.96%, respectively
for the extract, and 62.5879.70%, 49.6976.68% and
86.9278.47%, respectively for dexamethasone (Fig. 2A, B and C).
The study developed by Lawrence et al. (2002) showed the
events related to inﬂammation after induction by oil croton. The
authors reported that in the ﬁrst 30 min vasoactive amines (his-
tamine and serotonin) are released and are responsible by the
edema formation. However, the neutrophil migration is evidenced
approximately 1 h after the injury (Calixto et al., 2003; Calder,
2006; Nicolaou et al., 2011).
Neutrophils are the ﬁrst leukocytes recruited into the injury
site. Their recruitment begins by resident macrophages and mast
cells that induce several control events that allow this recruitment
process, such as changes in endothelium cells, caused by in-
ﬂammatory mediators, as histamine and cytokines, and chemo-
kinesrelease (Kolaczkowska and Kubes, 2013). At the injury site,
these cells phagocyte the causative agentsof injury and releasen the levels of chemokine KC, cytokines IL-1β and TNF after induction of ear edema
mL/right ear, inner surface) for treated groups except the control, 30 min before
5 animals and the vertical lines indicate S.E.M. All samples were collected 6 h after
e (A) IL-1β (B) and TNF (C). Statistical analysis was performed with ANOVA followed
differ from the control group.
Fig. 4. Microscopic evaluation of pretreatment with topical cream containing A. moluccana 1% on the ear edema induced by topical application of croton oil.Mice received
topic pre-treatment (50 mL / right ear, inner surface) for the treated groups, except for control 30 min before the application of the croton oil (20 mL/right ear, outer surface).
Samples were collected 6 h after application of croton oil to the control group (B), Vehicle (C), semisolid containing A. moluccana extract (1%) (D) and dexamethasone (E). To
the naive group (A), samples were collected without there some kind of treatment. The brackets in the images show the thickness of the dermis, the black arrows identify
sebaceous glands, arrowhead identify blood vessels and the white arrows identify leukocyte inﬁltration. All were assessed in representative areas with increased 10x and
40x.
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maging agent, such as the reactive oxygen species. However, in the
case of noncontrolled inﬂammation, the interference in the neu-
trophil mobilization tothe injury site is an important therapeutic
strategy (Li and Ng, 2012; Silva et al., 2015). In fact, the re-
sultsobtained shown that after croton oil administration in ani-
mals pretreated with A. moluccana extract the neutrophil migra-
tion was signiﬁcantly reduced (41.5079.30%, Fig. 3). Quintão et al.
(2012) have also demonstrated that the treatment with A. mo-
luccanadried extract, using oral administration route, was capable
of drastically reducing the neutrophil migration induced by in-
traplantar injection of carrageenan. As mentioned before, the
neutrophil migration depends on the production and release of
chemokines. The release of the chemokine CXCL1/KC occurs ra-
pidly under several experimental conditions and plays an im-
portant role in inducing the neutrophils inﬂux, collaborating with
their migration to the injured tissue (Vieira et al., 2009; Ko-
laczkowsha and Kubes, 2013). As mentioned above, our study has
demonstrated that the extract administered topically signiﬁcantly
reduced the CXCL1/KC levels induced by croton oil, effect that
could be responsible for the leukocyte migration inhibition. Both
TNF and IL-1β also present important role in all cardinal signs of
inﬂammation (Sanz and Kubes, 2012; Barioni et al., 2013). This
data reinforce the idea that the extract could exerte its anti-in-
ﬂamatory effects blocking the action of important mediators re-
leased prior to the leukocytes migration.
The Fig. 4 shows the microscopy evaluation of the ear-tissue of
mice submitted to the croton oil-induced inﬂammation. Firstly, we
have analysed the histological parameters of naive animals, in
order to caractherize the skin normal morphology. The histological
analysis presented resident cells, without changes in the epi-
dermis and dermis, and cartilage. Dermis also presented a regular
connective tissue with abundant extracellular matrix, presence of
ﬁbroblasts, sebaceous glands and hair follicles, blood vesselsin
regular state (Fig. 4A). As expected, animals from control group
and treated with placebo showed signiﬁcant changes in the tissue
morphology when compared with naive mice (Fig. 4B and C). The
connective tissue in the dermis presented lower amount of ex-
tracellular matrix due to the increase in cell number that migrated
to the injured site, which was approximately 4 folds greater than
the naive mice, corroborating with the data obtained in MPO assay
(Zanusso-Junior et al., 2011). No signiﬁcant difference was found in
the number and morphology of sebaceous glands, hair follicles and
blood vessels, when compared to the naive group (Fig. 4A).
The groups treated with the semisolid containing A. moluccana
extract (1%) or dexamethasone presented higher number of blood
vessels (Fig. 4D and E), similar to placebo group. Regarding the
epidermis and dermis, dexamethasone-treated mice showed
thickness reduction and tissue characteristic quite similar to thenaive group. The group of mice treated with the extract presented
thickness reduction when compared with placebo-treated group,
although a slight way when compared with dexamethasone group.
The same thing happened with the cellular inﬁltrate, characteriz-
ing a signiﬁcant reduction in the inﬂammatory process.
In fact, the A. moluccana extract presents ﬂavonoids as 2″-O-
rhamnosylswertisin and α,β-amyrenone, which has demonstrated
potent antinociceptive and anti-inﬂamatory activity in the wri-
thing model induced by acetic acid whemadministered by oral
route. The effect promoted by extract was mediated by inhibiting
the neutrophil migration and IL-1β release after carrageenan and
CFA-induced mechanical nociception (Cechinel-Filho, 2000;
Quintão et al. 2012; 2014).
Together, these results presented herein reinforce the popular
use of this herbal product presenting signiﬁcanttopical effect of
the semisolid containing A. moluccana dried extract against skin
inﬂammatory process. This effect seems to be related with the
inhibition of neutrophil migration and inﬂammatory mediators’
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